is semaglutide in short supply Novo Nordisk comments on role of off-label use Ozempic shortfall Semaglutide shortage ends as FDA

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1 Trial)

For someone on a 0.25mg weekly dose, that is a 40-60% dosing error from a nearly invisible syringe misread

The findings come from a recent phase 3B clinical trial which revealed substantial health improvements when patients took daily oral doses of semaglutide at 25 mg and 50 mg rather than the standard 14 mg dose

[12] IMPORTANT SAFETY INFORMATION : Contact your healthcare provider immediately if you experience: Severe, persistent abdominal pain, with or without vomiting (possible pancreatitis) Pain in the upper right abdomen, fever, or yellowing of skin/eyes (possible gallbladder problems) Minimal urination, dizziness, or extreme thirst (possible kidney problems) Severe abdominal distention or inability to pass gas or stool (possible intestinal obstruction) Persistent vomiting or diarrhea can lead to dehydration and electrolyte imbalances requiring medical attention

If it doesnt, contact a healthcare provider